Connect to other sites within the UBM Medica Network
Freelance science writer and frequent Cancer Network and OncoTherapy Network contributor.
Follow Her on Twitter
Metformin May Not Improve Pancreatic Cancer Survival
Metformin, a common drug for type II diabetes, did not improve the survival of patients with pancreatic ductal adenocarcinoma.
Top Highlights From the 2015 AACR Annual Meeting
This slide show features some of the top highlights from the 2015 American Association for Cancer Research (AACR) Annual Meeting.
Benefits of Multi-Gene Panel Testing for Breast Cancer Risk
A multi-gene panel test provides better diagnostic yield compared with a limited BRCA1/2 genetic test for patients at risk for hereditary breast cancer.
HPV Vaccine Can Protect Previously Exposed Patients
The HPV 16/18 vaccine protects women from cervical, anal, and oral HPV infections that can lead to cancer, including some women previously exposed to HPV.
Targeted Therapy Combo Shows Benefit in Breast and Ovarian Cancer
Combination treatment with the PARP inhibitor olaparib plus the PI3K inhibitor BKM120 showed a benefit in subsets of breast cancer and ovarian cancer patients.
Metastatic Prostate Cancer Patients Respond to PARP Inhibitor
Men with metastatic castration-resistant prostate cancer that had mutations in DNA repair genes were more likely to respond to the PARP inhibitor olaparib.
Nighttime Fasting Decreases Breast Cancer Risk
Women who spend less time eating each day and an increased amount of hours fasting overnight had a decreased risk of breast cancer.
MPDL3280A Shows Activity in Triple-Negative Breast Cancer
In an ongoing study, the immunotherapy MPDL3280A continues to be well-tolerated and to show signs of activity in triple-negative breast cancer patients.
Are Prostate and Other Cancer Risks Overestimated?
Too many people are being screened, diagnosed, and treated for certain types of cancer, according to two cancer researchers.
MRI Screening for Individuals at High Risk for Pancreatic Cancer
An MRI screening program for individuals at high risk for pancreatic cancer may be effective, according to the results of a short-term study.
By clicking Accept, you agree to become a member of the UBM Medica Community.